The contrasting roles of RAC2 in ccRCC and BC indicate the need for context-specific research to clarify the exact molecular mechanism by which RAC2 impacts tumor progression in different cancer types. The gene discussed is RAC2; the disease is nonpapillary renal cell carcinoma.